Many reports of an excessive incidence of congenital abnormalities in subjects with malignant disease have appeared in recent years (Miller, 1966; Sy and Edmonson, 1968; Kobayashi, Furukawa, and Takatsu, 1968) . With the exception of the association of leukaemia and Down's syndrome (Bernard et al., 1955; Carter, 1958;  Krivit and Good, 1957) , and the occurrence of malignant lymphomata in patients with immune deficiency states (Peterson, Cooper, and Good, 1965) , the concurrence of these conditions has not been shown to be greater than could be attributed to chance, as pointed out by Sy and Edmonson when discussing neuroblastoma. However, in the survey carried out by Kobayashi et al. (1968) recording major and minor anomalies including abnormal dermatoglyphs, an extremely high incidence of malformation was found. The incidence of anomalies recorded was 35% for neuroblastoma, 58% for nephroblastoma, 45% for hepatoblastoma, and 17% for gonadal teratomas.
In an attempt to determine whether major congenital anomalies were found in greater frequency in patients presenting with malignant disease, an examination of the records of cases of neuroblastoma, nephroblastoma, hepatoblastoma, and teratoma seen at The Hospital for Sick Children, Great Ormond Street, was made. These tumours were selected to include neurectodermal, mesodermal, and germ cell origins. 
Results
The anomalies found are shown in the Tables I  to IV. Table V indicates the anomalies found in association with 'occult' neuroblastoma (vide infra).
Both cases of talipes equinovarus included required active treatment, and surgical correction of pes cavus (No. 4, Table IV) was necessary in the case described.
Statistical treatment consisted of the use of Poisson's exponential summation to compare expected and observed frequencies of the incidence ofmalformation, using the figure of26 * 7 malformed/ 1000 (Leck et al., 1968) to determine the expected frequency.
The children in the group of sacrococcygeal (1) Patent ductus arteriosus, diaphragmatic hernia, hypoplasia of right lung (2) Aortic stenosis, hypoplastic aorta, patent ductus arteriosus (3) Rubella syndrome, patent ductus arteriosus, cardiomegaly, situs inversus, abnormal spleen (4) Atrial septal defect, ventricular septal defect, transposition of the great arteries, tricuspid atresia (5) Portal vein malformation (diffuse), cerebellar medulloblastoma teratomata show an increase in frequency of major malformation (6/63) which is significant (p = 0-011). However, if those anomalies attributable to local growth effects (see below) are excluded, the incidence (3/63) is not significantly different from normal (p = 0 35). In no other group was a significant increase in the incidence of malformation found. The probability of the observed frequency differing significantly from that expected was p = 0 37 for the remaining teratomata, p = 0-32 for nephroblastoma, p = 0 30 for hepatoblastoma, and p = 0 35 for neuroblastoma.
Defects discovered at operation or necropsy are not included in the calculations, for reasons discussed below. Discussion When attempting to examine the possible association of two groups of diseases, the method of comparison of figures of incidence is critical. If 'general incidence' figures of congenital malformations in a population are the basis of comparison, then the inclusion of defects discovered as a result of the malignancy is not valid, since these defects might not normally be found.
The inclusion of 'occult' tumours, such as those reported by Beckwith and Perrin (1963) and in series such as those of Sy and Edmonson, is also misleading. In previously reported cases, as in the 5 cases in Table V , death occurred as a result of the concurrent malformations, thereby increasing the apparent incidence of abnormality associated with neuroblastoma.
For our comparison, the figures of Leck et al. (1968) for the incidence of malformations in patients followed to the age of 6 years are taken as likely to represent complete ascertainment of externally diagnosable malformations. These authors pointed out that internal malformation such as horseshoe kidney or Meckel's diverticulum would not be recorded in this kind of survey unless they caused symptoms or were discovered at necropsy. They also found that, for similar reasons, minor but conspicuous abnormalities, e.g. accessory auricles and digits, might be missed. For this reason, only major anomalies are considered in this study.
The figure of '26-7 malformed per 1000' was derived from the study of Leck et al. (1968) . Other comparable series from different centres have shown rates of between 22 and 27 per 1000 for major malformations (McDonald, 1958 (McDonald, , 1961 Ward and Irvine, 1961; Smithells, 1968) .
It is only in the group of teratomata that there appears to be an excessive incidence of abnormalities if our findings are examined in a manner comparable to that used in these studies. It is of interest to note that three of the five major malformations seen in the sacrococcygeal group of teratomata were defects of development of the hind gut and 'cloacal' region, and might possibly be related to the presence of a locally proliferating tumour during develop-ment; in all of these cases the tumour mass was present at birth.
The finding of hemihypertrophy in 2 cases of nephroblastoma is in accordance with the findings of other workers (Miller, Fraumeni, and Manning, (1964) . These cases, if included as congenital malformations, would increase the incidence of major anomalies associated with nephroblastoma to 6 :103, and would suggest an association as noted by Miller (1966) by Miller (1966) , is confirmed in this study.
Apart from the suggested local effects, no specific group of anomalies is found in association with any tumour, the distribution of major defects in the whole series being consistent with the 'normal' incidence of various anomalies.
From our results, any significant association between the presence of congenital abnormalities and tumours may be explained by local growth effects.
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